Rockwell Medical (RMTI) Non Operating Interest Expenses (2019 - 2026)

Rockwell Medical (RMTI) has reported Non Operating Interest Expenses for 8 consecutive years, with $281000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses rose 1.81% year-over-year to $281000.0; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (down 0.87% YoY), and the FY2025 full-year result was $1.1 million, down 10.37% from the prior year.
• Non Operating Interest Expenses was little changed at $281000.0 in Q2 2026 per RMTI's latest filing, from $282000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.1 million in Q4 2023 and bottomed at $232000.0 in Q2 2024.
• Historically, Non Operating Interest Expenses has averaged $399000.0 across 5 years, with a median of $344500.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses soared 152.39% in 2023, then tumbled 73.92% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $439000.0 in 2022, then jumped by 152.39% to $1.1 million in 2023, then plunged by 73.92% to $289000.0 in 2024, then slipped by 1.04% to $286000.0 in 2025, then retreated by 1.75% to $281000.0 in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $281000.0, $282000.0, and $286000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.